Publications

Jiang H, Chen J, Li Y, Lin PF, He JG, Yang BB. Prevalence of mitochondrial DNA mutations in sporadicpatients with nonsyndromic sensorineural hearing loss. Braz J Otorhinolaryngol, 2015, 2015 (11).

Jiang H, Chen J, Shan XJ, Li Y, He JG, Yang BB. Prevalence and range of GJB2 and SLC26A4 mutations in patients with autosomal recessive nonsyndromic hearing loss. Molecular Medicine Reports, 2014,10 (1):379-386.

Shen KR, Zhang SD, Zhao L, Yang BB. Role of EGFR as a prognostic factor for survival in head and neck cancer: a meta-analysis. Tumour Biology, 2014, 35 (3): 2285-2295.

Yan MX, Zheng D, Li Y, Zheng Q, Chen J, Yang BB. Biodegradable Nasal Packings for Endoscopic Sinonasal Surgery: A Systematic Review and Meta-Analysis. PLos One 2014, 9(12).

Liu L ,Yang BB. Acoustically evoked short latency negative responses in hearing loss patients with enlarged vestibular aqueduct. Acta Neurologica Belgica, 2013,113 (2): 157-160.

Shoude Zhang, Beibei Yang, et al. Anti-epidermal growth factor receptor therapy for advanced head and neck squamous cell carcinoma: a meta-analysis. Eur J Clin Pharmacol, 2012;68(5):561-569. 

Jia Chen, Beibei Yang, et al. Antitumor potential of SLPI promoter controlled recombinant caspase-3 expression in laryngeal carcinoma. Cancer gene therapy, 2012;19(5):328-335. 

Beibei Yang, Hua Jiang, Jia Chen, et al. Dentritic Cells Pulsed With GST–EGFR Fusion Protein: Effect in Antitumor Immunity Against Head And Neck Squamous Cell Carcinoma. Head Neck, 2010;32: 626–635. 

Beibei Yang, Jia Chen, Xing Zhang, Jiang Cao. Expression of Epidermal Growth Factor Receptor variant III in laryngeal carcinoma tissues. Auris Nasus Larynx, 2009; 36:682-687. 

Jiang H, Yang BB. p53, epidermal growth factor receptor and proliferating cell nuclear antigen in laryngeal squamous cell carcinoma are not predictive markers for the effect of adjuvant radiotherapy. Acta Otolaryngol, 2009, 129(1):101-7.